Lincomycin Hydrochloride Injection shortage
To Be Discontinued 3 presentations · 2 manufacturers · first FDA posting Feb 25, 2026 · last update Mar 26, 2026
Manufacturers: Pfizer Inc., XGen Pharmaceuticals DJB, Inc.
Stated reasons (per FDA): Not stated
More info: FDA Drug Shortages Database · ASHP drug shortages list (search there for this drug)
Presentations
| Presentation | Manufacturer | Status | Reason | Notes (FDA) | Dates |
|---|---|---|---|---|---|
| Lincocin, Injection, 2 mL multiple dose vial (NDC 0009-0104-04) | Pfizer Inc. | To Be Discontinued | — | Discontinuation of the manufacture of the drug | Posted Feb 25, 2026 Updated Feb 25, 2026 Discontinued Feb 25, 2026 |
| Lincomycin Hydrochloride, Injection, 600 mg/2 mL vial x 10 count (NDC 39822-0350-2) | XGen Pharmaceuticals DJB, Inc. | To Be Discontinued | — | A business decision was made to discontinue manufacture of the drug. | Posted Mar 26, 2026 Updated Mar 26, 2026 Discontinued Mar 26, 2026 |
| Lincomycin Hydrochloride, Injection, 3 grams/10 mL vial x 10 count (NDC 39822-0355-6) | XGen Pharmaceuticals DJB, Inc. | To Be Discontinued | — | A business decision was made to discontinue manufacture of the drug. | Posted Mar 26, 2026 Updated Mar 26, 2026 Discontinued Mar 26, 2026 |